Environment and health has been working its way up the agenda rapidly over the last decade or so, partly on the back of concerns about climate change. However, putting that global issue to one side, other more local environmental issues are becoming better understood where more immediate benefits can be obtained at a national or local level. The basic paradigm for tackling environmental exposures and their influence on health requires an understanding of the sources of emissions, the level of exposures, to what extent these exposures influence health and consequent decisions on control measures. Effectiveness of introduction of these controls can then be assessed by monitoring either reductions in exposure or effects on health (Figure 1 ). This is well understood in the occupational setting; one of the best examples in the respiratory field being the introduction of coal dust exposure limits to reduce the rates of pneumoconiosis. The main problem with non-occupational environmental exposures is that they are often not so easily characterized and lie much lower on the dose-response curve leading to greater uncertainty about causal relationships and therefore the ability of control measures to effect significant improvements in health.
The environment can be considered at three levels:
• the global environment; • the macroenvironment; • the microenvironment.
For any individual, the latter two will vary often markedly on a day-to-day basis. The microenvironment can be considered as the place or area an individual occupies at any given time. This will, therefore, on any given day, be a reflection of the mix of the home environment, the work environment and the time travelling between the two, as well as those environments to which individuals are exposed during leisure time ( Figure 2 ). The macroenvironment covers the larger area, that is, whether the individual lives in an urban or synergistic effects making assessments of potential effects and the benefits of interventions challenging.
Identifying causal relationships between exposures and outcomes is the first necessary step before introducing an intervention aimed either at control of emissions or at control of exposures. Some are easy to introduce, some are not. Some exposures are within the control of the individual (e.g., environmental tobacco smoke (ETS) in the home), whereas others are not (e.g., the weather). At a global level, the spectre of climate change is the dominant issue, impacting on a range of diseases where only governments are able to exert an influence through legislation.
Exposures and outcomes
Although for pulmonary disease the non-occupational environment provides great potential for adverse reactions through inhaled exposures to a range of pollutants and allergens, the relationship between the magnitude and duration of exposure and health outcomes is still uncertain for many exposures. Differentiation has to be made between short and longterm exposures, as these will result in different health outcomes. Consequently, justification of institution of an intervention and estimation of benefit from an intervention will depend on the magnitude of the outcome and its importance. A small exposure but repeated over a long period of time may be more important in public health terms than the short-lived, higher exposure. If the information available to make a decision on an intervention is limited, the precautionary approach is sometimes then invoked in the absence of what might be seen as sufficient science, especially if the effect sizes are small. Sometimes resistance is met when attempting to intervene where an effect is small, but these effect sizes are averages from a total population, which will likely include those who are and those who are not susceptible to the effects of the exposure. Consequently, for the susceptible as a group, the effect sizes will be greater. One such susceptibility factor is the genetic make-up. The geneticists are currently extremely good at identifying gene polymorphisms which are potentially relevant in terms of health effects, but the exposure assessment field lags behind in producing sufficiently accurate data. 1, 2 To be fair, genes remain the same throughout life (although their activity may change), whereas exposures will vary over time making true cumulative exposure difficult to assess when considering long-term health effects. Such exposure estimates will usually be reliant on an individual's memory of what they might have been exposed to at different times both qualitatively and quantitatively with very little, if any, measured information on specific exposures. Despite these shortcomings, much has been achieved, although in the future this will improve once specific biomarker methodology improves.
It is also important to consider environmental exposures not simply in terms of the inhalation of toxic substances. For instance, it can be regarded that diet/nutrition is an environmental exposure, but for reasons of space this is not covered here. The weather clearly has an impact on patients with lung disease. Cold air will cause an attack of asthma in an individual, and during the winter months, there is a clear threshold below which mortality rates show an incremental increase. Heat waves are associated with marked increases in respiratory and cardiac mortality. 3, 4 Equally, climate change will result in an increase in temperature and changes in relative humidity, and this, apart from having a direct effect on the individual, will also affect plant distribution and therefore pollen exposure. 5 Certain vectors of disease will be affected, notably mosquitoes, and warming will be associated with more cholera outbreaks over wider areas. 6 Most infectious diseases require an intermediate host to transmit disease from one person to another and require a favourable environment to complete their life cycle. Although this is less likely to affect respiratory illness directly, there are some specific examples where climate has contributed to lung disease burden. For instance, harsh ecological conditions followed by favorable weather were responsible for the Hantavirus pulmonary syndrome outbreak in 1993 in USA, 7 resulting in a 42% mortality in otherwise healthy individuals. 8 Lastly, there is the issue of how the local environment allows better or worse access to medical care. 9 The whole speciality of rural and remote medicine has developed because of difficulties in obtaining medical care to populations living a long way away from their nearest physician. 10 For lung conditions, management of life-threatening asthma and exacerbations of chronic obstructive pulmonary disease (COPD) and managing a tension pneumothorax are obvious examples. On a day-to-day basis, chronic management of disease is facilitated if access to the local practitioner is eased. The simple provision of a bridge across a river or a better road is environmental improvement, which facilitates improved medical care and can be regarded as beneficial environmental exposure.
The most important non-occupational exposures in the context of lung disease are ambient air pollution and indoor air pollution at home.
Air pollution

Outdoor air pollution
The effect of air pollution on health has been recognized for many years, but as the main contributor to air pollution in the wake of the industrial revolution was from industrial emissions, and industry meant jobs, and polluted air was regarded as an acceptable price to pay. The 1952 London fog incident, resulting in at least 4000 additional deaths, 11, 12 (many would say as many as 10 000) was followed by legislative intervention in the form of the 1956 Clean Air Act, the first clean air legislation in the world. Its impact was remarkable, and over the 1960s and 1970s, advice to the UK government was that air pollution would no longer be a problem with respect to health. There was thus some concern in the 1980s when work from the US Six Cities Study reported health effects from what were regarded as low levels of air pollution, ranging from symptoms through to mortality. 13 The effect sizes were small which raised doubts in some quarters but since then a considerable body of evidence has accrued confirming associations between day-to-day changes in pollutant levels and health outcomes such as symptoms, lung function, hospital admissions and mortality. 14 Intriguingly, the majority of these effects are due to cardiovascular disease, 15 but here we will focus solely on respiratory effects.
The pollutants of concern and their sources are summarized in Table 1 but the most important are particles, ozone and sulphur dioxide. Air quality standards (AQSs) are set by each nation's government and are health based. The particle AQS for the UK at present is set at 50 g/m 3 of PM 10 (particles with a mass median diameter of Յ10 m) averaged over a 24 h period. In the USA, a PM 2.5 AQS has been established and there are currently moves to use the same metric as the new EU particle standard. The AQS for ozone (a secondary pollutant made by the action of UV light on vehicle emissions) is based in the UK on a moving 8 h average to appropriately allow for the hours of sunlight when ozone formation is at its greatest. Nitrogen dioxide should be regarded as a good marker of traffic-generated pollution, but at low levels seen in most cities, it is unlikely that it has a direct toxic effect on the respiratory tract. Reported associations between nitrogen dioxide and health effects can most likely be explained by confounding, nitrogen dioxide probably acting as a marker for another air pollutant metric such as particle numbers.
Air pollution from non-vehicular or industrial sources can also be a problem, good examples of which are the forest fires and their effects in Indonesia and Malaysia which were associated with considerable respiratory morbidity in the indigenous population as well as those involved in fire control. 16 Similar problems were also seen in the wake of 9/11 where workers at ground zero have become affected by reactive airways dysfunction syndrome, 17 and it is likely that the non-occupationally exposed population will also prove to be at risk. Fires can give rise to smoke inhalation injury, 18 but these are specific exposures in general, affecting only small number of the population. Outcomes will depend on what was being burnt, although often the effects are less than that might be expected, as was the case with the burning of oil wells 
Air pollution and asthma
Air-pollution exposure can affect some asthmatic individuals on a day-to-day basis, although the picture is not consistent. Panel studies in the USA which follow patients with asthma over time relating day-to-day changes in symptoms and peak-flow changes in air pollutants have shown some associations with symptoms and lung function in children from ozone and particle exposure, but studies in Europe have been largely negative. 19 Nevertheless, there is evidence to support increased hospital admissions with higher levels of particles and to some extent ozone and also some evidence that living on main roads with heavy traffic flow is associated with greater risk of exacerbations and hospital admissions. 20, 21 However, the pattern of symptoms in those children living on main roads is more typically that of cough and sputum rather than wheeze and breathlessness. Although this suggests that exposure to air pollution is associated with respiratory symptoms, this may not be all asthma. The information on hospital admissions for asthma in relation to air pollution exposure is, in general, rather patchy, but there does seem to be an association across the age groups. 19 There is no relationship with mortality at all, although this may be simply because the number of asthma deaths is too small to show an effect.
However, does exposure to air pollution turn a nonasthmatic individual into an asthmatic one, that is, initiation rather than exacerbation? The epidemiology to date provides only very limited support for this possibility, and if there is an effect, the contribution is likely to be small. The main argument against this possibility is that during the period in the 1970s and 1980s when asthma morbidity increased in the UK, all measures of air pollution were falling. Unless a different pollutant (e.g., a specific component of particles) or a different air pollution metric (e.g., particle numbers) were rising over the same period, this might be regarded as defining evidence against such a possibility. However, there is a mechanistic logic behind the fact that air pollutants, in particular particles and ozone, might be able to prime the airways, thus allowing the individual to develop asthma ab initio. Inflammatory reactions to air pollutants have been demonstrated, which are similar to those seen in asthma, 22, 23 and work from California has shown that exposure to higher levels of air pollution is associated with slower lung growth in children, 24 although at least partly reversibly. Exposure to diesel exhaust potentiates the production of allergenspecific IgE, 25 whereas there is evidence that exposure to ozone increases an asthmatic subject's airway response to grass pollen challenge. 26 The same has been shown for nitrogen dioxide exposure and house dust mite challenge 27 when considering the equivalent combination of exposures for indoor air, but these are reactions in individuals with established asthma -they do not apply to the development of sensitization. At present, it is reasonable to assume that exposure to air pollution over time is not associated with the development of asthma, but can have an effect on airway inflammation. Whether such an effect is relevant to the later development of COPD remains to be seen.
Chronic obstructive pulmonary disease
Day-to-day changes in particles and probably sulphur dioxide result in increased hospital admissions for COPD, with approximately a 3% increase in admissions for a 10 g/m 3 rise in PM 10 . 28, 29 Similar effect sizes are seen for mortality, but there are only limited data on day-to-day symptom patterns. There is likely to be a contribution to the prevalence and severity of COPD from long-term exposure to the type of air pollution seen in the developed world today, although the more sulphurous air pollution from industry and coal burning of pre-Clean Air Act days (and today seen in many other cities worldwide) is associated with increased prevalence of bronchitis in children and cough and sputum production in adults. Longitudinal studies such as the American Cancer Society study of over 150 cities have demonstrated that long-term exposures to particles are associated with life shortening in a dose-response manner. 30 It has been estimated that if annual PM 2.5 levels were reduced in the UK by 1 g/m 3 life expectancy of a cohort born now would be extended by one month (although likely much longer when just considering those susceptible to air pollution). 31 The mechanisms for these effects are likely mediated through oxidant stress. 32 Ozone is a strong oxidant as are particles where transition metal content may be important, 33 although in some areas of the world the acidity of the particle-based aerosol may be relevant.
Interventions
Interventions affecting levels of air pollution reduce respiratory morbidity and mortality. In 1991, the sale of coal in Dublin was banned resulting in more than a 70% reduction in ambient particle levels and a significant improvement in respiratory mortality over the ensuing three years 34 with a similar effect following an equivalent intervention in Hong Kong. After German re-unification, rates of bronchitis in children fell in old East Germany in line with reductions in sulphur dioxide and smoke. 35 There is thus no doubt that legislation aimed at improving ambient air quality will improve health. The present suggestion being debated in Europe about a change in AQS to a PM 2.5 -based standard will, if taken up at the proposed levels, represent effectively a slackening of control for current member states, and while this may still prove challenging for new member states, continuing downward pressure on levels of air pollution is essential if the benefits already seen from improving air quality is maintained. The effect of climate change on air pollutants are addressed below.
Indoor air pollution
We spend 85-90% of our lives indoors so the indoor environment is more important than many appreciate. In the developed world, the most important indoor air pollutant is ETS, whereas in the developing world biomass smoke is the key exposure.
Environmental tobacco smoke
ETS contains over 4000 chemicals with a range of potential toxicities ranging from carcinogenesis to inflammation. On a milligram for milligram basis, ETS is four to six times more toxic than mainstream smoke, 36 so it is not surprising that ETS has been shown to have easily measurable health effects.
ETS exposure in children is associated with an increased risk of developing asthma and an increased risk of respiratory symptoms, 37 although the effects on adults living with smokers are less marked. However, it is well recognized and accepted now that long-term exposure to ETS is associated with around a 20% increased risk of lung cancer. 38 Recent work has shown that health quality is impaired in COPD patients exposed to ETS in the home. 39 This knowledge has led to increasing legislation around the world to control ETS exposure in public places. The recent smoking ban in Scotland resulted in an 86% reduction in ETS exposure in pubs and bars 40 which has been followed by short-term improvements in lung function and in symptoms even in non-asthmatic individuals. 41, 42 One concern expressed as a result of the smoking bans, however, is that smoking will be displaced to the domestic environment with increased exposures particularly to children, although as yet this is speculative.
The ability of ETS to cause inflammation is well recognized, although it is only recently that ETS has been shown to contain endotoxin, 43 a known proinflammatory molecule. Exposure to endotoxin in other contexts has been associated with protection against asthma in children 44 and conversely increases in cough and sputum in adults 45, 46 but its role in ETS toxicity remains to be elucidated.
Allergens
The story behind indoor allergen exposure and the development and then potentiation of asthma is long and confusing. There is some evidence to suggest that exposure to house dust mite is associated with increased sensitization and the risk of developing asthma, 47 but allergen reduction studies have been very disappointing in terms of improved symptoms and in any case are intrusive and difficult to undertake. [48] [49] [50] Timing may be critical and it would appear that the environment to which the young infant is exposed may be the time where allergen control is likely to exert most benefit.
Volatile organic compounds
Domestic exposure to volatile organic compounds (VOCs) has been incriminated as a cause of respiratory symptoms, but the evidence is very varied. The situation is analogous to the sick building syndrome, where a range of subjective symptoms seem to be associated with inadequate ventilation and humidification systems. 51 How well these findings can be extrapolated to the domestic setting is not clear, although there is some evidence from Australia that reduction in VOC exposures in school children at school was associated with improved respiratory endpoints. 52 It is at least plausible that VOCs have the capacity to act as potentiators of other respiratory-active hazards such as allergens.
Domestic exposure to formaldehyde, a common volatile now rated as a class 1 carcinogen by IARC, is low but there may be a small risk of lung cancer in those more highly exposed.
Radon
Radon is produced from a range of natural rocks, notably granite, and exposure domestically is associated with a small increased risk of lung cancer. 53 
Cleaning agents
Regular occupational exposure to cleaning agents is associated with respiratory symptoms, notably irritantinduced asthma. 54 However, one study from the ALSPAC cohort has shown a positive correlation between exposure to cleaning agents in the home and increased wheeziness and respiratory symptoms in primary schoolage children. 55 This raises the distinct possibility that domestic exposure to chemicals may prove to be important in the genesis and progression of chronic airway inflammation. This news should result in a better understanding of the potential toxicity of a wide range of chemicals on the genesis of lung disease. 56 
Biomass smoke
It is estimated that globally 2.5 to 3 billion people (approximately half the world's population and up to 90% of rural households in developing countries) rely on traditional biomass fuels (wood, charcoal, animal dung and crop wastes) and coal. 57 Exposure to indoor air pollution may be responsible for nearly 2 million excess deaths in developing countries, representing just under 4% of disability-adjusted life years lost, consequences of which are comparable with those of tobacco use and which are only exceeded by those of malnutrition (16%), unsafe water and sanitation (9%) and unsafe sex (4%). 57 Exposure to biomass smoke is associated with acute respiratory infections and exacerbations of lung disease 58, 59 and an increased prevalence of chronic bronchitis (nearly 20%) in the hilly region of Nepal. 60 Intervention by introduction of flued stoves has shown improvement in the proportion of individuals with COPD. 61, 62 The best way to intervene in this situation therefore appears to be either a change in fuel (e.g., to kerosene) or encouraging the community to be in a position to provide themselves with flued stoves and so become independent of donations from outside.
Climate
Current evidence indicates that climate change will contribute to the global burden of diseases, in particular infectious diseases, vector-borne diseases and malnutrition, 6 being more marked in developing countries as they lack financial resources to provide adequate facilities to meet the challenges and are equipped with fewer public health networks to meet the changing demand. However, climatic conditions, along with climate change, affects respiratory health.
Extreme cold temperatures
For patients with lung disease, cold weather is associated with increased hospital admissions for COPD, 63, 64 whereas overall mortality increases during cold snaps, largely due to cardiopulmonary disease. 65, 66 A reduction in lung function is associated with cold weather, whether during outdoor excursions or indoor. 63 A 1°C decrease in mean temperatures below 5°C is associated with a Ͼ10% increase in all respiratory consultations in primary care. 67 For many people with asthma, cold air is a potent broncho-constrictor, particularly in combination with exercise, 68 probably by airway cooling and mediator release. Most asthmatic individuals are aware of this and take precautions such as avoiding exercise on a cold day.
Extreme heat
Higher temperature extremes are also an important cause of respiratory morbidity and probably mortality. The heat waves in Paris and Greece 69 over the last decade showed marked increases in mortality, notably in people over the age of 60, again largely affecting people with cardiopulmonary disease. Interestingly, heat-related increase in deaths can occur at relatively low temperatures, and as hot days early in the summer are more likely to result in increased deaths than hot days later in the summer, a change in temperature may be more important than the absolute value itself. 70 The populations of big cities in developing countries might be more vulnerable as they lack infrastructure and resources to adapt to extreme heat, an issue for a range of environmental exposures in these countries (Figure 3 ). Conversely, increases in global temperatures may have some positive health effects, such as reductions in survival of intermediate hosts such as snails for schistosomiasis and lower winter mortality rates from respiratory disease in the northern hemisphere. 71 Intervention in the context of temperature extremes is limited to warning patients with chronic lung disease to take precautions during periods of high or low temperatures. There are plans in some countries to assess the potential for weather-based warnings given out through a range of media on exacerbation rates in patients with chronic lung disease, although at present the evidence that this approach would help is limited.
Interactions between environmental variables
Climate change also has the potential to affect the duration of specific allergen seasons. Exposure to concentrations of CO 2 present today (370 ppm), and those projected for the mid-twenty-first century (600 ppm) increases ragweed pollen production by 131 and 320%, respectively, compared with plants grown at pre-industrial CO 2 levels (280 ppm). 72 Consequently, the combination of enhanced pollen production, warmer temperatures (and consequent increased ozone production) will lead to greater risks of asthma attacks in susceptible individuals.
Thunderstorms and aeroallergens
Some specific weather conditions are known to be adverse for people with asthma. While levels of airborne aeroallergens (e.g., grass pollen) vary according to temperature and rainfall, consequently having different effects year on year, 71 short-lived variations in meteorology may have more dramatic effects. Thunderstorm asthma was first described in Birmingham in 1983 73 and later in the South Eastern part of the UK 74, 75 where a storm caused many attacks of asthma resulting in casualty departments running out of nebulized therapy and an increased use of intensive care beds. Thunderstorm asthma is largely due to an allergic response to grass pollen. During rain or periods of increasing relative humidity, freshly released pollen grains osmotically rupture to release sub-micronic packages of allergen. As a result, pollen counts (simply a count of intact pollen grains) fall during periods of rain but allergen levels increase. 67 The Birmingham outbreak was characterized by high numbers of affected individuals with grass pollen asthma who believed that they 'only' had hay fever and so had no inhalers to fall back on to relieve their wheezing. However, the situation is probably more complex than this. A thunderstorm is very often associated with a nose of cold air which precedes the arrival of the rain and which may therefore come as a cold initial snap after what is often a warm and sultry period prior to the storm. It is therefore entirely conceivable that the combination of the brief spell of cold air plus a high dose of inhalable grass pollen allergen combine to cause symptoms in those susceptible.
Asthma-related hospital admission are positively associated with airborne pollen levels and pollen types, independent of co-exposure to air pollutants and meteorological factors, 76, 77 although this is not always so clear cut. [78] [79] [80] [81] [82] [83] However, the osmotic rupture theory suggests that the relationship between grass pollen allergen and asthma may not be best approached by the use of grass pollen counts. 84
Flood
Many Asian countries such as Bangladesh, India, Nepal, China and some African countries experience heavy flooding, mostly during the rainy season, leading to severe health risks including respiratory infections, the second most common illness reported during the 1988 flood in Bangladesh. 85, 86 
Air pollutants
Climate change may affect exposures to air pollutants by affecting weather and thereby local and regional pollution concentrations, by affecting anthropogenic emissions such as increased fuel combustion for power generation and by affecting natural sources of air pollutant emissions.
One example of how climate change may affect a specific pollutant involving more than one of these pathways is ozone. Trophospheric ozone is formed in the atmosphere by the reaction of volatile organic compounds and NO x with UV light. Ozone is an important pollutant, but levels are highest downwind of the major areas of population because of the slow atmospheric chemistry of ozone formation, so exposures are highest in areas of lower population. Because the substrate for ozone formation is vehicle emissions, attempts to reduce these emissions will have an effect on ozone production locally, and it is of interest that over the last decade in the UK, there have been fewer high ozone days. However, background levels of ozone have risen, clearly documented on the west coast of Ireland, well away from any local sources of pollution and this background rise is due to northern hemispheric transport of ozone from North America. It is likely, therefore, that ozone will rise over the next few decades in the context of global warming and consequently exposures in the UK to ozone may well increase as well as in other parts of the world.
The implications are clear, namely that such increases are likely to have an effect not only on individuals with lung disease in terms of exacerbations, but perhaps also on those without existing lung disease. In the UK, these possibilities are currently being considered by both the UK's Committee on Medical Effects of Air Pollutants and the Royal Society.
Summary
Many environmental factors can influence the burden of respiratory disease acting in a wide range of ways both indoors and outdoors. Although in many cases we have little influence over such exposures (e.g., weather conditions), there are many (ETS exposure and outdoor air pollution) where interventions can improve health and advice to individuals in these settings will confer benefit. How climate change may affect pulmonary disease remains debatable, but it is possible that heatassociated changes in allergen exposures may be more than counterbalanced by potential reductions in coldrelated exacerbations of diseases such as COPD.
